Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-25-005417
Filing Date
2025-12-30
Accepted
2025-12-30 07:10:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 7641
  Complete submission text file 0000902664-25-005417.txt   9363
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Subject) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-90530 | Film No.: 251611052
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 780 THIRD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address 780 THIRD AVENUE 30TH FLOOR NEW YORK NY 10017 718-570-6018
Caligan Partners LP (Filed by) CIK: 0001727492 (see all company filings)

EIN.: 822603419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A